# Eloralintide Side Effects: What Studies and Users Report

Source: https://pepvault.app/peptides/eloralintide/side-effects

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Library](https://pepvault.app/peptides) [Eloralintide](https://pepvault.app/peptides/eloralintide) Side effects

Peptide questions · Eloralintide

# Eloralintide side effects: what studies and users report

Reviewed November 2026 Evidence: Moderate [Published by PepVault](https://pepvault.app/guides/how-we-research)

The side effects most commonly reported for eloralintide are nausea, fatigue and constipation, among 8 the library lists; the library’s evidence on it includes controlled trials in people.

Its safety note opens: eloralintide has no label: it is still in trials.

## What is commonly reported with eloralintide

- Nausea
- Fatigue
- Constipation
- Diarrhea
- Vomiting
- Decreased appetite
- Hair thinning
- Injection site reaction

Common here means the library lists it among the effects people most often report; the list doesn’t say how often each one happens.

Each effect, and the other metabolic & GLP-1 compounds the library lists it for

| Effect | Also listed for (of 24) |
| --- | --- |
| Nausea | 21: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 17 more |
| Fatigue | 7: Semaglutide, Tirzepatide, Retatrutide, Dulaglutide and 3 more |
| Constipation | 13: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 9 more |
| Diarrhea | 20: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 16 more |
| Vomiting | 18: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 14 more |
| Decreased appetite | 9: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 5 more |
| Hair thinning | None: listed for Eloralintide alone |
| Injection site reaction | 1: Mazdutide |

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Track eloralintide in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=q-side-effects-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Which eloralintide side effects the metabolic & GLP-1 group shares

Across the 25 metabolic & GLP-1 compounds in the library, the effects listed most often are nausea (22 of 25), diarrhea (21 of 25), vomiting (19 of 25) and constipation (14 of 25). Eloralintide shares 7 of its 8 listed effects with at least one other metabolic & GLP-1 compound; hair thinning is listed for eloralintide alone.

## More on eloralintide

### Eloralintide

- [Eloralintide: the full reference](https://pepvault.app/peptides/eloralintide)
- [Eloralintide dose guide](https://pepvault.app/lab/dosage/eloralintide)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/eloralintide-10mg)

### Studies

- [Eloralintide: 2.6% to 11.3% weight loss at 12 weeks in phase 1](https://pepvault.app/research/eloralintide-bhattachar-2026)
- [Eloralintide: -4.4% body weight at week 4 in a single-dose trial](https://pepvault.app/research/eloralintide-briere-2025)
- [All 2 studies](https://pepvault.app/research#eloralintide)

### Compared with

- [Cagrilintide vs Eloralintide](https://pepvault.app/peptides/compare/cagrilintide-vs-eloralintide)
- [Eloralintide vs Petrelintide](https://pepvault.app/peptides/compare/eloralintide-vs-petrelintide)
- [Tirzepatide vs Eloralintide](https://pepvault.app/peptides/compare/tirzepatide-vs-eloralintide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Eloralintide questions

- [Eloralintide: half-life](https://pepvault.app/peptides/eloralintide/half-life)
- [Eloralintide: how long it takes to work](https://pepvault.app/peptides/eloralintide/how-long-to-work)
- [Eloralintide: what it’s stacked with](https://pepvault.app/peptides/eloralintide/stacks)

### Terms on this page

- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)

## What the eloralintide safety notes say

> The library’s safety note
>
> Eloralintide has no label: it is still in trials. In the 48-week phase 2 trial, nausea affected 11% on 1 mg and 13% on 3 mg (about the same as 14% on placebo), and 25% to 64% on the higher doses; fatigue rose with dose to 43% to 46% at 9 mg vs 12% on placebo. Most of these were mild to moderate, and Lilly reported fewer of them with a slower step-up. The trial's posted results also list a slower heart rate (bradycardia) in a few people on 6 and 9 mg and none on placebo, and hair thinning in about 1 in 9 on 9 mg (6 of 54) and none on placebo. In Lilly's later trial in type 2 diabetes, 0% to 10.8% on eloralintide alone stopped for side effects. Long-term safety is not yet known. These are trial findings to review with your clinician.

> The library’s interaction note
>
> No interaction studies have been published. In the phase 1 trial, eloralintide slowed stomach emptying only a little after the first dose, and the effect faded with weekly dosing, so the authors expect less delay to oral medicines than with older amylin drugs; this still needs confirming. It is not a GLP-1, and Lilly is testing it on top of tirzepatide (EloraTZP), but the GI side effects add up in the pair. With insulin or a sulfonylurea, discuss glucose monitoring with your clinician.

These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.

## Where the eloralintide reports come from

The library rates the evidence on eloralintide as moderate: animal studies plus some human data.

Of the library’s 8 research notes on eloralintide, 6 rest on randomized trials and 2 on clinical data.

Our 2 study pages on eloralintide: 2 randomized trials.

So eloralintide has controlled trials in people to set its listed effects against.

## What our eloralintide study pages report on safety

### Eloralintide: 2.6% to 11.3% weight loss at 12 weeks in phase 1

Randomized trial, human, 2026: Appetite loss was the side effect seen most often, in 19% of people on the drug; others included COVID-19 (11%), fatigue (11%) and headache (12%), and most side effects were mild. Gut problems were less frequent, with vomiting in 4%, nausea in 8% and diarrhea in 10%.

- [Read the study page: Eloralintide: 2.6% to 11.3% weight loss at 12 weeks in phase 1](https://pepvault.app/research/eloralintide-bhattachar-2026)

### Eloralintide: -4.4% body weight at week 4 in a single-dose trial

Randomized trial, human, 2025: In the human trial, participants on eloralintide reported 16 adverse events, and 15 of the 16 were mild; there were 4 gastrointestinal events, including one moderate vomiting event. The human part was a small phase 1 safety trial of single doses in healthy people, with weight checked at week 4, so it does not show long-term weight loss or safety in people with obesity.

- [Read the study page: Eloralintide: -4.4% body weight at week 4 in a single-dose trial](https://pepvault.app/research/eloralintide-briere-2025)

## Questions people ask

### What are the side effects of eloralintide?

The side effects most commonly reported for eloralintide are nausea, fatigue and constipation, among 8 the library lists; the library’s evidence on it includes controlled trials in people.

### Do eloralintide’s side effects come from human studies?

The library rates the evidence on eloralintide as moderate, and the library’s evidence on it includes controlled trials in people.

### Which eloralintide side effects are its own?

Among the metabolic & GLP-1 compounds, the library lists hair thinning for eloralintide alone.

### Does eloralintide interact with other medicines?

The library’s interaction note on eloralintide begins: No interaction studies have been published.

## More on eloralintide

- [Eloralintide: the full library page](https://pepvault.app/peptides/eloralintide)
- [Eloralintide dose guide](https://pepvault.app/lab/dosage/eloralintide)
- [Eloralintide: half-life](https://pepvault.app/peptides/eloralintide/half-life)
- [Eloralintide: how long it takes to work](https://pepvault.app/peptides/eloralintide/how-long-to-work)
- [Eloralintide: what it’s stacked with](https://pepvault.app/peptides/eloralintide/stacks)

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=q-side-effects-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Track eloralintide in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=q-side-effects-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Track eloralintide in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=q-side-effects-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## More on eloralintide

### Eloralintide

- [Eloralintide: the full reference](https://pepvault.app/peptides/eloralintide)
- [Eloralintide dose guide](https://pepvault.app/lab/dosage/eloralintide)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/eloralintide-10mg)

### Studies

- [Eloralintide: 2.6% to 11.3% weight loss at 12 weeks in phase 1](https://pepvault.app/research/eloralintide-bhattachar-2026)
- [Eloralintide: -4.4% body weight at week 4 in a single-dose trial](https://pepvault.app/research/eloralintide-briere-2025)
- [All 2 studies](https://pepvault.app/research#eloralintide)

### Compared with

- [Cagrilintide vs Eloralintide](https://pepvault.app/peptides/compare/cagrilintide-vs-eloralintide)
- [Eloralintide vs Petrelintide](https://pepvault.app/peptides/compare/eloralintide-vs-petrelintide)
- [Tirzepatide vs Eloralintide](https://pepvault.app/peptides/compare/tirzepatide-vs-eloralintide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Eloralintide questions

- [Eloralintide: half-life](https://pepvault.app/peptides/eloralintide/half-life)
- [Eloralintide: how long it takes to work](https://pepvault.app/peptides/eloralintide/how-long-to-work)
- [Eloralintide: what it’s stacked with](https://pepvault.app/peptides/eloralintide/stacks)

### Terms on this page

- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Track eloralintide in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=q-side-effects-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Eloralintide

- [Eloralintide in the library](https://pepvault.app/peptides/eloralintide)
- [Eloralintide: half-life](https://pepvault.app/peptides/eloralintide/half-life)
- [Eloralintide: how long it takes to work](https://pepvault.app/peptides/eloralintide/how-long-to-work)
- [Eloralintide: what it’s stacked with](https://pepvault.app/peptides/eloralintide/stacks)

## Tools

- [Peptide half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [Peptide dosage calculator](https://pepvault.app/tools/peptide-dosage-calculator)

## The library

- [The peptide reference library](https://pepvault.app/peptides)
- [Peptide comparisons](https://pepvault.app/peptides/compare)
- [The peptide glossary](https://pepvault.app/glossary)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
